Close
Contact

Contact us

BioSyngen is developing multiple T-cell immunotherapies with the aim to address a wide range of malignancies.

SINGAPORE HEADQUATERS

Taiseng Exchange
Avenue

Taiseng Exchange, 5 Tai Seng Avenue, #08-51/52/53/54 , Tower C, Singapore 536671


GUANGZHOU, CHINA

Sino-Singapore
Knowledge City

1-3F, Block B, Building 6, Chuangyan Street, Sino-Singapore Knowledge City, Huangpu District, Guangzhou, P. R. China


WRITE TO US

Enquiries
are welcome.

Name
EMAIL ADDRES
PHONE NUMBER
Message